Cochrane · systematic review · CD014908
Risk of thromboembolism in patients with COVID‐19 who are using hormonal contraception
Ramanadhan, S, Hansen, K, Henderson, JT, et al. · Cochrane Database of Systematic Reviews · 2023 · Cochrane Library
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
12
current version
GRADE rated
6
No studies
6
Included studies
NR
No studies 6 · 50%Ungraded 0 · 0%Very low 6 · 50%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Show all 2 versionsSummary of findings table ‐ Combined hormonal contraception (estrogen plus progestin) compared to no contraception for COVID‐19 positive patients
Population: COVID‐19 positive patients
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Mortality Summary of findings table ‐ Combined hormonal contraception (estrogen plus progestin) vs no contraception | OR 1 [0.41, 2.4] | 1 study · 18892 participants | Very low Downgraded: risk of bias, imprecision, indirectness |
Hospitalization Summary of findings table ‐ Combined hormonal contraception (estrogen plus progestin) vs no contraception | OR 0.79 [0.64, 0.97] | 1 study · 295689 participants | Very low Downgraded: risk of bias, imprecision, indirectness |
Venous thromboembolism Summary of findings table ‐ Combined hormonal contraception (estrogen plus progestin) vs no contraception | no estimate extracted | 2 studies · 13 participants | Very low Downgraded: risk of bias, imprecision |
Intubation Summary of findings table ‐ Combined hormonal contraception (estrogen plus progestin) vs no contraception | no estimate extracted | 1 study · 7 participants | Very low Downgraded: risk of bias, imprecision |
Arterial thromboembolism ‐ not measured Summary of findings table ‐ Combined hormonal contraception (estrogen plus progestin) vs no contraception | no estimate extracted | NR | No studies |
Acute respiratory distress syndrome ‐ not measured Summary of findings table ‐ Combined hormonal contraception (estrogen plus progestin) vs no contraception | no estimate extracted | NR | No studies |
Summary of findings table ‐ Any type of hormonal contraception (estrogen plus progestin or progestin‐only) compared to no contraception for COVID‐19 positive patients
Population: COVID‐19 positive patients
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Hospitalization Summary of findings table ‐ Any type of hormonal contraception (estrogen plus progestin or progestin‐only) vs no contraception | OR 0.99 [0.68, 1.44] | 1 study · 123 participants | Very low Downgraded: risk of bias, imprecision, indirectness |
Intubation Summary of findings table ‐ Any type of hormonal contraception (estrogen plus progestin or progestin‐only) vs no contraception | no estimate extracted | 1 study · 123 participants | Very low Downgraded: risk of bias, imprecision, indirectness |
Mortality ‐ not measured Summary of findings table ‐ Any type of hormonal contraception (estrogen plus progestin or progestin‐only) vs no contraception | no estimate extracted | NR | No studies |
Venous thromboembolism ‐ not measured Summary of findings table ‐ Any type of hormonal contraception (estrogen plus progestin or progestin‐only) vs no contraception | no estimate extracted | NR | No studies |
Arterial thromboembolism ‐ not measured Summary of findings table ‐ Any type of hormonal contraception (estrogen plus progestin or progestin‐only) vs no contraception | no estimate extracted | NR | No studies |
Acute respiratory distress syndrome ‐ not measured Summary of findings table ‐ Any type of hormonal contraception (estrogen plus progestin or progestin‐only) vs no contraception | no estimate extracted | NR | No studies |